4-(2-amino-6-chloro-9h-purin-9-yl)-1,3-dioxolane-2-methanol has been researched along with anisomycin in 1 studies
Studies (4-(2-amino-6-chloro-9h-purin-9-yl)-1,3-dioxolane-2-methanol) | Trials (4-(2-amino-6-chloro-9h-purin-9-yl)-1,3-dioxolane-2-methanol) | Recent Studies (post-2010) (4-(2-amino-6-chloro-9h-purin-9-yl)-1,3-dioxolane-2-methanol) | Studies (anisomycin) | Trials (anisomycin) | Recent Studies (post-2010) (anisomycin) |
---|---|---|---|---|---|
27 | 0 | 5 | 1,357 | 0 | 319 |
Protein | Taxonomy | 4-(2-amino-6-chloro-9h-purin-9-yl)-1,3-dioxolane-2-methanol (IC50) | anisomycin (IC50) |
---|---|---|---|
Glucose transporter | Leishmania mexicana | 0.225 | |
Hexose transporter 1 | Plasmodium falciparum (malaria parasite P. falciparum) | 0.326 | |
Solute carrier family 2, facilitated glucose transporter member 1 | Homo sapiens (human) | 0.321 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fuortes, MG; Merlin, LR; Rico, MJ | 1 |
1 other study(ies) available for 4-(2-amino-6-chloro-9h-purin-9-yl)-1,3-dioxolane-2-methanol and anisomycin
Article | Year |
---|---|
Distinctions between persistent and reversible group I mGluR-induced epileptiform burst prolongation.
Topics: Analysis of Variance; Animals; Anisomycin; Benzophenanthridines; Dioxolanes; Drug Synergism; GABA Antagonists; Guinea Pigs; Hippocampus; In Vitro Techniques; Methoxyhydroxyphenylglycol; Phospholipase D; Picrotoxin; Protein Synthesis Inhibitors; Purines; Receptors, Metabotropic Glutamate | 2010 |